Follow us
HOME
OUR STORY
TRACK RECORD
TEAM
INVESTORS
FUNDS
PORTFOLIO
IMPACT
SFDR
NEWS
CONTACT
No
Yes
Ok
EQT Life Sciences leads $42M funding round in Phagenesis
read full story
EQT LIFE SCIENCES LEADS €30M SERIES C FUNDING ROUND IN ONERA
read full story
EQT LS PORTFOLIO COMPANY
EQT Life Sciences Co-Leads VectorY’s €129 Million ($138 Million)
read full story
EQT LS portfolio company Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
read full story
EQT LS COMPANY NEWS
EQT Life Sciences invests in $61 Million financing of AstronautX
read full story
EQT LS COMPANY NEWS
EQT Life Sciences Leads €54 Million Upsized Financing in MinervaX
read full story
EQT LS COMPANY NEWS
EQT Life Sciences largest investor in Agomab’s USD 100 million Series C financing
read full story
EQT Life Sciences closes Dementia Fund at the hard cap
read full story
ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023
read full story
EQT LS COMPANY NEWS
EQT Life Sciences Co-leads $88 Million Series B Financing in QurAlis
read full story
go to archive
Follow us
Menu
HOME
OUR STORY
TRACK RECORD
TEAM
INVESTORS
FUNDS
PORTFOLIO
IMPACT
SFDR
NEWS
CONTACT
No
Yes
Ok
EQT Life Sciences leads $42M funding round in Phagenesis
EQT Life Sciences leads €30M Series C funding round in Onera
EQT Life Sciences Co-Leads VectorY’s €129 Million ($138 Million)
EQT LS portfolio company Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
EQT Life Sciences invests in $61 Million financing of AstronautX
EQT Life Sciences Leads €54 Million Upsized Financing in MinervaX
EQT Life Sciences largest investor in Agomab’s USD 100 million Series C financing
EQT Life Sciences closes Dementia Fund at the hard cap
ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023
EQT Life Sciences Co-leads $88 Million Series B Financing in QurAlis
go to archive
X
MONTHLY REPORTS
Here you can subscribe for the monthly report of the LSP Life Sciences Fund
First Name:
Last Name:
Email:*
Company: